Joshua Levinson
Retina Specialist · Greenbelt, MDNPI 1982960936
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations.
Across 101 payments — averaging $37.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$566
- AbbVie$508
- Genentech USA, Inc.$435
- Novartis$392
- Astellas Pharma US Inc$313
- Apellis Pharmaceuticals, Inc.$283
- plus $1K from 15 others
Across 136 payments — averaging $461.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kyowa Kirin, Inc.$59K
- Notal Vision, Inc.$4K
What the payments were for
- Food & beverage$3,775100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $566 |
| AbbVie(2 entities) | 22 | $508 |
| Genentech USA, Inc. | 18 | $435 |
| Novartis | 6 | $392 |
| Astellas Pharma US Inc | 8 | $313 |
| Apellis Pharmaceuticals, Inc. | 9 | $283 |
| Alcon | 2 | $256 |
| Alimera Sciences, Inc. | 3 | $192 |
| Genentech, Inc. | 2 | $180 |
| Rxsight Inc | 2 | $151 |
| Kala Pharmaceuticals, Inc. | 1 | $125 |
| Dutch Ophthalmic, USA | 1 | $88 |
| Amgen | 2 | $53 |
| ANI Pharmaceuticals, Inc. | 2 | $52 |
| Astellas Pharma Global Development | 2 | $46 |
| Notal Vision, Inc. | 2 | $35 |
| Sandoz | 1 | $28 |
| Eyepoint US, Inc. | 1 | $25 |
| Bausch & Lomb Americas Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $15 |
| Philips North America LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,775 in reported general payments places this provider in the 55th percentile of 47 retina specialist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 74 | $3,303 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $674 |
| Latanoprost | 27 | $673 |
| Ketorolac Tromethamine | 28 | $530 |
| Brimonidine Tartrate | 17 | $258 |
| Ofloxacin | 20 | $231 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Greenbelt
- Reginald SandersGreenbelt$24K
- Mohsin AliGreenbelt$14K
- Mariam MathaiGreenbelt$4K
- Sneha PadidamGreenbelt$4K
- Jason HuangGreenbelt$3K
- Collin OhningGreenbelt$1K
- Geoffrey KaplanGreenbelt$792
- Rohit LakhanpalOwings Mills$168K
- Brian DoChevy Chase$116K
- Adam GerstenblithHagerstown$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.